CTEV

Claritev Corporation

$28.67

19.46%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators.

Source: Yahoo Finance
AI summary

Price & performance

1M+16.3%
3M-15.8%
YTD-15.4%
1Y-50.4%
52-week range—
Beta1.75
Full chart and returns against a benchmark

Q-Score

44/ 100

Quality against peers; 50 is the peer median.

Growth42
Risk35
Performance52
Valuation47
Profitability55
Leverage44
Sentiment59
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$965.4M+3.7%
Net income-$284.3M
Net margin-29.4%+147.4 pts
Historical fundamentals

Red flags in filings

1active red flag
Material weakness in controlsFeb 26, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer29%
Regions, segments, customers and suppliers

Valuation

CTEVIndustryP/E—67.40P/S0.484.25EV/EBITDA35.1844.97P/B—6.14PEG—0.25
Dividend yield0.00%
Every valuation metric

Earnings

Nov 9next report, before the open
EPS estimate$1.71
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate